Cargando…
Identification and Validation of a GPX4-Related Immune Prognostic Signature for Lung Adenocarcinoma
Lung adenocarcinoma (LUAD) is a commonly occurring histological subtype of lung cancer. Glutathione peroxidase 4 (GPX4) is an important regulatory factor of ferroptosis and is involved in the development of many cancers, but its prognostic significance has not been systematically described in LUAD....
Autores principales: | Feng, Zhenxing, Li, Bo, Chen, Qingliang, Zhang, Hong, Guo, Zhigang, Qin, Jianwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130018/ https://www.ncbi.nlm.nih.gov/pubmed/35620733 http://dx.doi.org/10.1155/2022/9054983 |
Ejemplares similares
-
Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021) -
Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
por: Sun, Sijin, et al.
Publicado: (2020) -
Identification of an immune prognostic 11-gene signature for lung adenocarcinoma
por: Yang, Tao, et al.
Publicado: (2021) -
Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma
por: Zhang, Wentao, et al.
Publicado: (2023) -
Identification of a Combined RNA Prognostic Signature in Adenocarcinoma of the Lung
por: He, Si-Yu, et al.
Publicado: (2019)